NCT03594682 2018-07-20
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study
Beijing Chest Hospital
Phase NA Unknown
Clinical Trials
3 trialsNCT01929200 2015-05-22
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT01097317 2011-08-08
First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown